Compound information
- Natural Products
- ZC57221
- Molecular Formula
- C10H13NO3
- Molecular Weight
- 195.089543276 g/mol
- Structure
-
- IUPAC Name
- 6-(2,5-dioxopyrrol-1-yl)hexanal
- InChI
- InChI=1S/C10H13NO3/c12-8-4-2-1-3-7-11-9(13)5-6-10(11)14/h5-6,8H,1-4,7H2
- InChI Key
- ZWIGHFZUSGHZEZ-UHFFFAOYSA-N
- SMILES
- O=CCCCCCN1C(=O)C=CC1=O
- Source
- ZINC000022061941
Warheads
- Acrylamide
-
- Acrylamide
-
- Aldehydic carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 14 | Ring Count | 1 |
Heteroatom Count | 4 | Rotatable Bond Count | 6 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 54.45 Å2 | LogP | 0.911 |
LogS | -2.135 | LogD | 0.171 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.367 | Pgp substrate | 0.011 |
HIA | 0.962 | F20 % | 0.937 |
F30 % | 0.091 | Caco-2 | -4.594 |
MDCK | -4.428 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.974 | PPB | 68.207 |
VD | 0.682 | Fu | 0.426 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.897 | CYP1A2 substrate | 0.498 |
CYP2A6 substrate | 0.364 | CYP2B6 substrate | 0.515 |
CYP2C19 inhibitor | 0.215 | CYP2C19 substrate | 0.468 |
CYP2C8 substrate | 0.546 | CYP2C9 inhibitor | 0.047 |
CYP2C9 substrate | 0.02 | CYP2D6 inhibitor | 0.051 |
CYP2D6 substrate | 0.109 | CYP2E1 substrate | 0.635 |
CYP3A4 inhibitor | 0.014 | CYP3A4 substrate | 0.052 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.855 | CL | 3.898 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.02 | Hepatotoxicity | 0.416 |
Mutagenicity | 0.168 | Rat Oral Acute Toxicity | 0.378 |
FDAMDD | 0.192 | Skin Sensitization | 0.998 |
Carcinogenicity | 0.311 | Eye Corrosion | 0.959 |
Eye Irritation | 0.976 | Respiratory Toxicity | 0.079 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.433 | IGC50 | 3.744 |
LC50FM | 4.057 | LC50DM | 4.256 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.119 | NR-AR-LBD | 0.447 |
NR-AhR | 0.009 | NR-Aromatase | 0.15 |
NR-ER | 0.323 | NR-ER-LBD | 0.38 |
NR-PPAR-gamma | 0.844 | SR-ARE | 0.787 |
SR-ATAD5 | 0.609 | SR-HSE | 0.893 |
SR-MMP | 0.136 | SR-p53 | 0.806 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.